Robert Janknegt
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
Papers in
- Pharmacology 10
- Antibiotics Pharmacokinetics and Efficacy 10
- Pharmacogenetics and Drug Metabolism 3
-
- Antimicrobial Resistance in Staphylococcus 4
- Antifungal resistance and susceptibility 3
- Co-authors
- Irma A. J. M. Bakker‐Woudenberg (2 shared papers)Siem de Marie (1 shared paper)Daan J.A. Crommelin (1 shared paper)S. de Marie (1 shared paper)J.W.M. van der Meer (2 shared papers)Adri Steenhoek (1 shared paper)I.M. Gould (1 shared paper)E.E. Stobberingh (2 shared papers)
- Journals
- Expert Opinion on Pharmacotherapy (9 papers)Journal of Antimicrobial Chemotherapy (5 papers)PharmacoEconomics (3 papers)Peritoneal Dialysis International (2 papers)Pharmacoepidemiology and Drug Safety (1 paper)
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
Robert Janknegt
46 papers receiving 777 citations
Peers
Comparison fields: 5 of 101
- Applied Microbiology and Biotechnology 86
- Infectious Diseases 233
- Molecular Medicine 51
- Pharmacology 144
- Geriatrics and Gerontology 26
Countries citing papers authored by Robert Janknegt
This map shows the geographic impact of Robert Janknegt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Janknegt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Janknegt more than expected).
Fields of papers citing papers by Robert Janknegt
This network shows the impact of papers produced by Robert Janknegt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Janknegt. The network helps show where Robert Janknegt may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Janknegt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 223 | |
| 2 | 1994 | 113 | |
| 3 | 2000 | 47 | |
| 4 | 1997 | 38 | |
| 5 | 1994 | 36 | |
| 6 | 1993 | 35 | |
| 7 | 2008 | 34 | |
| 8 | 1996 | 22 | |
| 9 | 1989 | 21 | |
| 10 | 1993 | 19 | |
| 11 | 1997 | 19 | |
| 12 | 2017 | 14 | |
| 13 | 1990 | 13 | |
| 14 | 2007 | 12 | |
| 15 | 1991 | 11 | |
| 16 | 1996 | 11 | |
| 17 | 2017 | 11 | |
| 18 | 1991 | 10 | |
| 19 | 1994 | 9 | |
| 20 | 2007 | 9 |
About Robert Janknegt
Robert Janknegt is a scholar working on Pharmacology, Infectious Diseases, Pediatrics, Perinatology and Child Health, Epidemiology and Molecular Biology, having authored 48 papers that have together received 820 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Pneumonia and Respiratory Infections (7 papers), Pharmaceutical studies and practices (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Antibiotic Resistance in Bacteria (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Antifungal resistance and susceptibility (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (86 citations), Infectious Diseases (233 citations), Molecular Medicine (51 citations), Pharmacology (144 citations) and Geriatrics and Gerontology (26 citations). Robert Janknegt has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Irma A. J. M. Bakker‐Woudenberg, Siem de Marie, Daan J.A. Crommelin, S. de Marie, J.W.M. van der Meer, Adri Steenhoek, I.M. Gould, E.E. Stobberingh, W. J. A. Wijnands and Olaf H. Klungel. Their work appears in journals such as Expert Opinion on Pharmacotherapy, Journal of Antimicrobial Chemotherapy, PharmacoEconomics, Peritoneal Dialysis International and Pharmacoepidemiology and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.